Exploring Key Insights of the Vaccine Contract Manufacturing Market: Growth Prospects, Emerging Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the vaccine contract manufacturing market grown over the years?
There has been a significant expansion in the vaccine contract manufacturing market in the past few years. It is projected to scale up from $3.58 billion in 2024 to $3.93 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.7%. Factors such as limitations of conventional vaccine production, worldwide disease outbreaks escalating vaccine necessity, regulatory endorsement for contract manufacturing, rising intricacy in vaccine generation, and a boost in vaccine research and advancement have attributed to the growth in the previous period.
What Is the forecasted market size and growth rate for the vaccine contract manufacturing market?
We anticipate a swift expansion in the vaccine contract manufacturing market in the upcoming years. This market is predicted to reach $5.93 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. The anticipated surge in this forecast period can be credited to an increasing focus on pandemic readiness, enhanced pharmaceutical manufacturing outsourcing, the growth of biopharmaceutical firms, shortened vaccine development timelines, and worldwide efforts to ensure vaccine availability. Notable trends for this period will include the incorporation of single-use technology in production, a surge in tailored medical solutions for vaccine creation, the emergence of mRNA and viral vector vaccines, the adoption of continuous manufacturing strategies, and extension of fill-finish services.
Get your vaccine contract manufacturing market report here!
What are the major factors driving growth in the vaccine contract manufacturing market?
The upward thrust in initiatives promoting immunizations is anticipated to fuel the expansion of the vaccine contract manufacturing market in the future. Vaccination is a straightforward, safe, and effective approach to prevent infectious diseases. It amplifies the immune response and augments the body’s resistance to pathogens. The surge of initiatives promoting vaccinations could improve and innovate different vaccine synthesis methods, thus facilitating contract manufacturing of vaccines. For instance, the US Department of Health and Human Services, an executive department of the US federal government, declared a new investment of $350 million in November 2022. This funding was for HRSA (Health Resources and Services Administration) supported health establishments to accelerate the delivery of COVID-19 vaccines efficaciously to their local populations, focusing particularly on underserved individuals. Hence, the escalation in initiatives promoting vaccinations is fostering the expansion of the vaccine contract manufacturing market.
What key areas define the segmentation of the global vaccine contract manufacturing Market?
The vaccine contract manufacturing market covered in this report is segmented –
1) By Service Type: Fill-Finish, Bulk Product
2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines
3) By Process: Downstream, Upstream
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By End-Use: Human Use, Veterinary
Subsegments:
1) By Fill-Finish: Aseptic Fill-Finish, Lyophilization, Vial Filling, Syringe Filling
2) By Bulk Product: Cell Culture, Microbial Fermentation, Antigen Production, Buffer Preparation
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12216&type=smp
What are the top market players propelling the growth of the vaccine contract manufacturing industry?
Major companies operating in the vaccine contract manufacturing market include Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Fujifilm Holdings Corporation, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Icon plc, Lonza Group AG, Cytiva, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Albany Molecular Research Inc., Soligenix Inc., Bio Farma, Curia Global Inc., Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH, Bharat Biotech, Goodwin Biotechnology Inc., Biofabri S.L
What are the key trends shaping the future of the vaccine contract manufacturing market?
There is an emerging trend of strategic collaborations in the vaccine contract manufacturing sector. Notably, large firms are seeking alliances with other entities in the same sector to maintain market dominance. For example, in January 2023, Australian biotech firm Vaxxas, known for its innovative needle-free vaccine technology, teamed up with Norway’s Coalition for Epidemic Preparedness Innovations to finance and guide the production of new vaccines. This collaboration would also support Vaxxas’ needle-free vaccine patch technology, potentially eliminating the need for frozen storage for mRNA vaccines. Additionally, in October 2024, Germany’s LenioBio joined forces with American CDMO ReciBioPharm, aiming to boost its protein production capabilities and expedite vaccine production. This partnership aligns with LenioBio’s plan to broaden its CEPI-funded project’s reach, which intends to showcase the rapidity and effectiveness of its proprietary ALiCE protein expression technology in manufacturing vaccine-related proteins for use in clinical trials.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12216
What regions are dominating the vaccine contract manufacturing market growth?
North America was the largest region in the vaccine contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in the vaccine contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2024
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
